Found: 162
Select item for more details and to access through your institution.
"World in motion" – emulsion adjuvants rising to meet the pandemic challenges.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00418-0
- By:
- Publication type:
- Article
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00402-8
- By:
- Publication type:
- Article
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00419-z
- By:
- Publication type:
- Article
Pneumococcal capsule blocks protection by immunization with conserved surface proteins.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00413-5
- By:
- Publication type:
- Article
Protein engineering strategies for rational immunogen design.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00417-1
- By:
- Publication type:
- Article
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00420-6
- By:
- Publication type:
- Article
A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00416-2
- By:
- Publication type:
- Article
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00414-4
- By:
- Publication type:
- Article
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00409-1
- By:
- Publication type:
- Article
Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00415-3
- By:
- Publication type:
- Article
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00407-3
- By:
- Publication type:
- Article
Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00412-6
- By:
- Publication type:
- Article
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00411-7
- By:
- Publication type:
- Article
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00410-8
- By:
- Publication type:
- Article
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00403-7
- By:
- Publication type:
- Article
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00381-w
- By:
- Publication type:
- Article
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00406-4
- By:
- Publication type:
- Article
Immune response against SARS-CoV-2 variants: the role of neutralization assays.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00404-6
- By:
- Publication type:
- Article
Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00408-2
- By:
- Publication type:
- Article
Molecular interactions between parasite and mosquito during midgut invasion as targets to block malaria transmission.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00401-9
- By:
- Publication type:
- Article
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00405-5
- By:
- Publication type:
- Article
Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00400-w
- By:
- Publication type:
- Article
Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00399-0
- By:
- Publication type:
- Article
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00395-4
- By:
- Publication type:
- Article
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00307-6
- By:
- Publication type:
- Article
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00394-5
- By:
- Publication type:
- Article
Distinct SARS-CoV-2 antibody reactivity patterns elicited by natural infection and mRNA vaccination.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00396-3
- By:
- Publication type:
- Article
A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00377-6
- By:
- Publication type:
- Article
Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00388-3
- By:
- Publication type:
- Article
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00393-6
- By:
- Publication type:
- Article
Protein-based antigen presentation platforms for nanoparticle vaccines.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00330-7
- By:
- Publication type:
- Article
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00391-8
- By:
- Publication type:
- Article
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00392-7
- By:
- Publication type:
- Article
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00387-4
- By:
- Publication type:
- Article
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00389-2
- By:
- Publication type:
- Article
A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00385-6
- By:
- Publication type:
- Article
Long-term protective immunity induced by an adjuvant-containing live-attenuated AIDS virus.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00386-5
- By:
- Publication type:
- Article
An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00390-9
- By:
- Publication type:
- Article
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00384-7
- By:
- Publication type:
- Article
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00383-8
- By:
- Publication type:
- Article
Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00382-9
- By:
- Publication type:
- Article
The shot, the message, and the messenger: COVID-19 vaccine acceptance in Latin America.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00380-x
- By:
- Publication type:
- Article
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00381-w
- By:
- Publication type:
- Article
Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00363-y
- By:
- Publication type:
- Article
Deimmunization of flagellin for repeated administration as a vaccine adjuvant.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00379-4
- By:
- Publication type:
- Article
Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00378-5
- By:
- Publication type:
- Article
Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00376-7
- By:
- Publication type:
- Article
Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00371-y
- By:
- Publication type:
- Article